In 2024, the U.S. Drug Enforcement Administration (DEA) indicated they intend to reclassify cannabis to be a Schedule III drug. This rescheduling will identify that cannabis has legitimate healthcare reasons and will help open up the door to investigate on other probable treatment employs.And try to remember: for the reason that hemp CBD still is n